A digital health application designed to address the often overlooked emotional and psychosocial consequences of multiple sclerosis has shown significant benefits in a randomized controlled trial involving 470 people with the disease. The application, called levidex, was associated with improved disease-specific quality of life after six months when added to usual care, according to findings from the LAMONT study published in Multiple Sclerosis …
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.